NEWER ANTIDEPRESSANTS: Beyond Selective Serotonin Reuptake Inhibitor Antidepressants

作者: Brian J. McConville , Robert O. Chaney , Kerri L. Browne , Loren Friedman , Elizabeth Cottingham

DOI: 10.1016/S0031-3955(05)70067-5

关键词: AntidepressantSertralinePsychiatrySerotonin reuptake inhibitorTrazodoneMajor depressive disorderFluoxetineMedicineMirtazapineVenlafaxine

摘要: Major depressive disorder in children and adolescents is a significant problem also predictive indicator of severe long-term difficulties. 22,43 Although the phenomenology child adolescent depression versus adult held to be similar, 51 has not been shown clearly respond treatment with tricyclic antidepressants (TCAs) double-blind studies. More evidence may available for than adolescents. 1a,19,42 These generally negative findings have reviewed, 20 sudden unexplained deaths receiving desipramine 29,32,33,39 caused widespread concern about use TCAs Citing lack rigorous scientific supporting superiority compared placebo, along these deaths, Geller 17 Werry 52 expressed routine As noted article by Labellarte colleagues elsewhere this issue, emergence selective serotonin reuptake inhibitors (SSRIs) allowed further psychopharmacologic methods treating depression. Fluoxetine, fluvoxamine, sertraline, paroxetine found open studies provide effective antidepressant activity without sedating, anticholinergic, or cardiotoxic reactions observed TCAs, although incidence insomnia, nervousness, restlessness, anxiety are higher. 4,21,50 McConville 25 positive effects sertraline major that scale ratings frequently varied, being worsened adverse events improved life circumstances. There an endogenous component early childhood adolescence, either as pure syndrome following repeated stressors. 34 If stressors can lead nonreactive pattern, strong argument made psychotherapeutic intervention disorders double depressions (e.g., dysthymia disorder). Follow-up depressives suggests become long-term, causing debilitating problems, including only but impairment psychosocial educational functioning. 23,37 A few on SSRIs conducted. Simeon 45a did find statistically differences between fluoxetine placebo depression; however, important study Emslie colleagues, 12 which 96 were treated difference was among untreated groups Children's Depression Rating Scale Revised 36 Clinical Global Impression 28 In study, effect similar drug first week outpatient treatment; over 8-week period trial, emerged criteria earlier. 3 Therefore, efficacy exist both depressed provided sufficiently large sample used indicate response. addition, careful measurements must taken within single centers ensure inter-rater reliability. current clinical preference rather depression, hard from controlled minimal. Moreover, connection effectiveness medications their degree inhibition seems lacking. Further "traditional" needed, multidose disorders; needed more exploration newer alternate antidepressive agents. The section begins overview compounds leads into discussion most common practitioners, well some developments.

参考文章(48)
Edoardo S. Pescatori, Judith C. Engelman, Gordon Davis, Irwin Goldstein, Priapism of the Clitoris: A Case Report Following Trazodone Use The Journal of Urology. ,vol. 149, pp. 1557- 1559 ,(1993) , 10.1016/S0022-5347(17)36450-9
A. Bagheri, Psychiatric problems among Iranian immigrants in Canada. The Canadian Journal of Psychiatry. ,vol. 37, pp. 7- 11 ,(1992) , 10.1177/070674379203700103
Schroeder Dh, Parler Dw, Casat Cd, Pleasants Dz, Bupropion in children with attention deficit disorder. Psychopharmacology Bulletin. ,vol. 25, pp. 198- 201 ,(1989)
Kiev A, Wisselink Pg, Shrivastava Rk, Feiger A, Wilcox Cs, Nefazodone versus sertraline in outpatients with major depression : Focus on efficacy, tolerability, and effects on sexual function and satisfaction The Journal of Clinical Psychiatry. ,vol. 57, pp. 53- 62 ,(1996)
Pleasants Dz, Casat Cd, Van Wyck Fleet J, A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin. ,vol. 23, pp. 120- ,(1987)
Valeri P, Piccinelli D, Cioli, Corradino C, Rocchi Mg, A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine. Pharmacological Research Communications. ,vol. 16, pp. 85- 100 ,(1984)
Bernard J. Carroll, Stephen C. Cook, H. Corzo, Elva O. Poznanski, Use of the Children's Depression Rating Scale in an inpatient psychiatric population. The Journal of Clinical Psychiatry. ,vol. 44, pp. 200- 203 ,(1983)
Baldwin Ds, Buckingham Sa, Ascher A, Maragakis Bp, Hawley Cj, Pover Gh, Abed Rt, Cox J, A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression. The Journal of Clinical Psychiatry. ,vol. 57, pp. 46- 52 ,(1996)
J L Parker, G S Sumner, M W Mandoki, M R Tapia, M A Tapia, Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacology Bulletin. ,vol. 33, pp. 149- 154 ,(1997)